Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hakan Buyukhatipoglu

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of the National Medical Association|October 24, 2008
A possibly overlooked side effect of Orlistat: gastroesophageal reflux diseaseHakan Buyukhatipoglu
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 29, 2008
A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic systemCelalettin Usalan, Hakan Buyukhatipoglu
Saudi Medical Journal|May 29, 2007
Correlation does not always show a causal relationshipHakan Buyukhatipoglu, Fatemeh Homaei-Shandiz
Asian Pacific Journal of Cancer Prevention : APJCP|November 26, 2014
Influence of ethnicity on survival of breast cancer patients in TurkeyAbdurahman Kuzhan, Mustafa Adli, Hakan Buyukhatipoglu
Clinical Rheumatology|December 20, 2005
Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failureCelalettin Usalan, Hakan Buyukhatipoglu, Ozlem Tiryaki
Nephrology (Carlton, Vic.)|May 18, 2010
Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patientsOzlem Tiryaki, Celalettin Usalan, Hakan Buyukhatipoglu
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 30, 2010
Plasma plasminogen activator inhibitor 1 (PAI-1) and P-selectin levels in urgent hypertension: effect of single dose captopril and nifedipine on fibrinolytic activityOzlem Tiryaki, Hakan Buyukhatipoglu, Celalettin Usalan
Nephrology (Carlton, Vic.)|January 22, 2009
Function of dynamically stimulated endothelium and renin-angiotensin-aldosterone system in normotensive subjects with a family history of hypertensionCelalettin Usalan, Hakan Buyukhatipoglu, Ozlem Tiryaki, et al.
Journal of General Internal Medicine|October 10, 2006
The value of urine specific gravity in detecting diabetes insipidus in a patient with uncontrolled diabetes mellitus: urine specific gravity in differential diagnosisErsin Akarsu, Hakan Buyukhatipoglu, Sebnem Aktaran, et al.
Nephrology (Carlton, Vic.)|February 14, 2007
Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infectionHakan Buyukhatipoglu, Ozlem Tiryaki, Kadir Tahta, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of the National Medical Association|October 24, 2008
A possibly overlooked side effect of Orlistat: gastroesophageal reflux diseaseHakan Buyukhatipoglu
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 29, 2008
A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic systemCelalettin Usalan, Hakan Buyukhatipoglu
Saudi Medical Journal|May 29, 2007
Correlation does not always show a causal relationshipHakan Buyukhatipoglu, Fatemeh Homaei-Shandiz
Asian Pacific Journal of Cancer Prevention : APJCP|November 26, 2014
Influence of ethnicity on survival of breast cancer patients in TurkeyAbdurahman Kuzhan, Mustafa Adli, Hakan Buyukhatipoglu
Clinical Rheumatology|December 20, 2005
Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failureCelalettin Usalan, Hakan Buyukhatipoglu, Ozlem Tiryaki
Nephrology (Carlton, Vic.)|May 18, 2010
Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patientsOzlem Tiryaki, Celalettin Usalan, Hakan Buyukhatipoglu
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 30, 2010
Plasma plasminogen activator inhibitor 1 (PAI-1) and P-selectin levels in urgent hypertension: effect of single dose captopril and nifedipine on fibrinolytic activityOzlem Tiryaki, Hakan Buyukhatipoglu, Celalettin Usalan
Nephrology (Carlton, Vic.)|January 22, 2009
Function of dynamically stimulated endothelium and renin-angiotensin-aldosterone system in normotensive subjects with a family history of hypertensionCelalettin Usalan, Hakan Buyukhatipoglu, Ozlem Tiryaki, et al.
Journal of General Internal Medicine|October 10, 2006
The value of urine specific gravity in detecting diabetes insipidus in a patient with uncontrolled diabetes mellitus: urine specific gravity in differential diagnosisErsin Akarsu, Hakan Buyukhatipoglu, Sebnem Aktaran, et al.
Nephrology (Carlton, Vic.)|February 14, 2007
Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infectionHakan Buyukhatipoglu, Ozlem Tiryaki, Kadir Tahta, et al.
Pageof 7